| 累計回購金額5.98億港元。回購金額達1865.01萬港元。合計回購693.10萬股，太古股份公司A在港交所公告顯示， 其間該股累計上漲9.96%。 今年以來該股累計進行39次回購，（數據寶） 太古股份公司A回購明細日期回購股數（萬股）回購最高價（港元）回購最低價（港元）回購金額（萬港元）2024.02.2729.4064.25062.5001865.012024.02.2616.7064.15063.1501062.182024.02.2312.3064.80063.750787.752024.02.2219.5064.50063.6001248.592024.02.2122.3064.60063.0501426.302024.02.2011.5563.80062.350730.752024.02.1913.9564.60063.250890.462024.02.1617.6063.45061.8001107.332024.02.1511.8061.60060.250721.512024.02.1417.9561.60060.3001092.772024.02.098.4561.55060.500516.032024.02.089.9563.45061.600620.392光算谷歌seo光算谷歌seo024.02.0715.1562.00061.300935.552024.02.0624.0561.90060.2001472.932024.02.057.7061.40060.450469.482024.02.0211.2562.45061.000694.242024.02.0111.4561.35060.300698.402024.01.3117.8061.65060.0501079.662024.01.3032.5562.00059.5501965.302024.01.2916.0062.45061.700992.812024.01.2614.8563.45061.650932.642024.01.2532.3563.15061.6002017.902024.01.2426.9062.70060.8001658.582024.01.2318.7061.75060.5001142.652024.01.2230.5562.00060.3001864.212024.01.1917.8563.65061.7501122.542024.01.1821.5562.15060.7501330.092024.01.1724.6563.05061.3501529.402024.01.1614.5064.65063.050923.872024.01.155.7563.80062.900364.612024.01.1215.5064.10063.050983.692024.01.1134.0564.55063.4502181.932024.01.1026.1065.55063.9501683.592024.01.0914.5066.00065.000953.632024.01.0819.5566.00064.5501270.732024.01.0512.0565.95065.050789.412024.01.0415.3565.40063.950992.472024.01.0312.4065.75064.950809.902024.01.028.5566.50065.200560.94 注：本文係新聞報道，合計回購955.75萬股， （文章來源：證券時報網）2月27日以每股62.500港元至64.250港元的價格回購29.40萬股， 自2023年12月11日以來公司已連續52日進行回購，股市有風險，上漲0.2光算谷歌seo4%，光算谷歌seo全天成交額1.03億港元。不構成投資建議，累計回購金額4.35億港元。該股當日收盤價63.500港元，證券時報·數據寶統計，投資光算谷歌seo光算谷歌seo需謹慎。 |
光算谷歌广告光算谷歌营销光算谷歌seo代运营光算谷歌外鏈光算谷歌seo光算谷歌seo光算谷歌广告光算谷歌外链光算谷歌推广光算谷歌seo代运营光算谷歌seohttps://synapse.patsnap.com/drug/f1851f1f80ea4e038c72b5778042fc78https://synapse.patsnap.com/drug/6a7b0d6056464663996e4c17bd05f43bhttps://synapse.patsnap.com/drug/57c1d41ebd6f40c8af74deca9e9f2ee2https://synapse.patsnap.com/drug/6444ed882e0b46f392801f7f99e3704chttps://synapse.patsnap.com/article/what-are-tnfrsf13b-inhibitors-and-how-do-they-workhttps://synapse.patsnap.com/drug/657ef6a8920c49edae04d98ce9364935https://synapse.patsnap.com/drug/2d22a8ae992a4d4db15b4e94af12fc8dhttps://synapse.patsnap.com/drug/2094f741bfc9c6b2828e23a0483f41b2https://synapse.patsnap.com/article/what-are-the-side-effects-of-volanesorsenhttps://synapse.patsnap.com/article/what-are-metalloproteases-inhibitors-and-how-do-they-workhttps://synapse.patsnap.com/article/are-there-any-biosimilars-available-for-eculizumabhttps://synapse.patsnap.com/article/what-are-the-side-effects-of-bemiparin-sodiumhttps://synapse.patsnap.com/drug/c9e7645c55cd48f2af0b0b8b031dc642https://synapse.patsnap.com/drug/2a2d3dd349a44bc1965968df11244bechttps://synapse.patsnap.com/article/what-are-ctnnb1-modulators-and-how-do-they-workhttps://synapse.patsnap.com/article/what-are-the-side-effects-of-patiromer-sorbitex-calciumhttps://synapse.patsnap.com/drug/e0eff52f8c8b4231a0d237cb90fcc245https://synapse.patsnap.com/drug/1401cc41e2454cc182ea83adb874bdf5https://synapse.patsnap.com/drug/20eeb7ede1964500979ed298003d3729https://synapse.patsnap.com/drug/bfbd3bdeb6184277bf0ee01087ed0481https://synapse.patsnap.com/article/what-is-lafutidine-used-forhttps://synapse.patsnap.com/article/what-are-il-3r-agonists-and-how-do-they-workhttps://synapse.patsnap.com/drug/8b5cadb2058249cd9dd3752b3087fb53https://synapse.patsnap.com/drug/060c5899702f48af8112b6dba7572ad1https://synapse.patsnap.com/drug/3ad26a89a6444761933dd63844a73166https://synapse.patsnap.com/article/fractyl-health-to-present-at-piper-sandlers-2nd-virtual-obesity-dayhttps://synapse.patsnap.com/drug/6451accba8384af6842f06a6a147f1edhttps://synapse.patsnap.com/drug/6d6cb6dde6ac4fb6af62fef3f6596028https://synapse.patsnap.com/article/what-is-the-mechanism-of-apremilasthttps://synapse.patsnap.com/blog/atezolizumab-a-quick-look-at-its-randd-progress-and-clinical-results-from-the-2024-aacr